| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A novel systems pharmacology platform to dissect action mechanisms of traditional Chinese medicines for bovine viral diarrhea disease
|
Zheng, Chunli
|
|
2016
|
94 |
C |
p. 33-45
13 p.
|
artikel
|
| 2 |
Benefits and challenges of a QSP approach through case study: Evaluation of a hypothetical GLP-1/GIP dual agonist therapy
|
Rieger, Theodore R.
|
|
2016
|
94 |
C |
p. 15-19
5 p.
|
artikel
|
| 3 |
Editorial Board
|
|
|
2016
|
94 |
C |
p. IFC-
1 p.
|
artikel
|
| 4 |
Improving drug safety with a systems pharmacology approach
|
Schotland, Peter
|
|
2016
|
94 |
C |
p. 84-92
9 p.
|
artikel
|
| 5 |
Novel minimal physiologically-based model for the prediction of passive tubular reabsorption and renal excretion clearance
|
Scotcher, Daniel
|
|
2016
|
94 |
C |
p. 59-71
13 p.
|
artikel
|
| 6 |
Systems pharmacology in drug development and therapeutic use — A forthcoming paradigm shift
|
Kloft, Charlotte
|
|
2016
|
94 |
C |
p. 1-3
3 p.
|
artikel
|
| 7 |
Systems pharmacology to predict drug safety in drug development
|
Trame, Mirjam N.
|
|
2016
|
94 |
C |
p. 93-95
3 p.
|
artikel
|
| 8 |
Systems pharmacology – Towards the modeling of network interactions
|
Danhof, Meindert
|
|
2016
|
94 |
C |
p. 4-14
11 p.
|
artikel
|
| 9 |
Top-down and bottom-up modeling in system pharmacology to understand clinical efficacy: An example with NRTIs of HIV-1
|
Duwal, Sulav
|
|
2016
|
94 |
C |
p. 72-83
12 p.
|
artikel
|
| 10 |
Towards patient stratification and treatment in the autoimmune disease lupus erythematosus using a systems pharmacology approach
|
Ruiz-Cerdá, M. Leire
|
|
2016
|
94 |
C |
p. 46-58
13 p.
|
artikel
|
| 11 |
Utilising the EGFR interactome to identify mechanisms of drug resistance in non-small cell lung cancer – Proof of concept towards a systems pharmacology approach
|
Saafan, Hisham
|
|
2016
|
94 |
C |
p. 20-32
13 p.
|
artikel
|
Tijdschrift beschrijving